Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Dactinomycin × 1 year × Clear all

Sponsor

Conditions

Rhabdomyosarcoma 4 Rhabdomyosarcoma, Embryonal 2 Wilms Tumor 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Sarcoma, Ewing 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Rhabdomyosarcoma, Alveolar 1 Pleuropulmonary blastoma 1 Hydatidiform Mole, Invasive 1 Histiocytoma, Malignant Fibrous 1 Gestational Trophoblastic Disease 1 Dermatofibrosarcoma 1 Choriocarcinoma 1 Beckwith-Wiedemann Syndrome 1

Interventions

Nivolumab 63 pembrolizumab 62 cabozantinib 43 Ipilimumab 33 Magnetic Resonance Spectroscopy 30 Specimen Handling 26 lenvatinib 21 Axitinib 20 belzutifan 16 Sunitinib 16 Radiosurgery 13 Biopsy 13 atezolizumab 10 Everolimus 10 CTLA-4 Antigen 10 pazopanib 9 avelumab 8 Radiotherapy 8 Bevacizumab 8 fludarabine 6 cemiplimab 6 aldesleukin 6 Standard of Care 6 Nephrectomy 6 Immunoglobulin G 6 Cyclophosphamide 6 toripalimab 5 spartalizumab 5 Paclitaxel 5 tivozanib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡